Pacific Biosciences unveiled Sprq‑Nx chemistry and a program to allow select customers to reuse SMRT cell consumables on Revio instruments, promising up to 40% per‑genome savings for large projects. PacBio said the moves will push consumable costs for a 20X human genome below $300, narrowing the price gap with short‑read providers. Separately, South Korea named PacBio’s HiFi platform the primary technology for its national pangenome reference project to sequence over 1,000 genomes, a commercial win that validates long‑read utility in large-scale population efforts.